[1]王建东,王绪林,董迎春,等.TaqMan探针检测结直肠癌血浆中微量 甲基化EphA7基因[J].医学研究与战创伤救治(原医学研究生学报),2009,11(02):97-99，130.
　WANG Jian-dong,WANG Xu-lin,DONG Ying-chun,et al.Microamount of hypermethylated EphA7 detected in plasma of colorectal cancer with a TaqMan probe[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(02):97-99，130.

点击复制

TaqMan探针检测结直肠癌血浆中微量 甲基化EphA7基因()

分享到62.8K

参考文献/References:

[1] Frattini M, Gallino G, Signoroni S, et al. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer [J].Cancer Lett,2008,263(2):170-181.
[2]Ludovini V,Pistola L,Gregorc V,et al.Plasma DNA,microsatellite alterations,and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients:a study of the perugia multidisciplinary team for thoracic oncology [J].J Thorac Oncol, 2008,3(4):365-373.
[3]Maheswaran S,Sequist LV,Nagrath S,et al.Detection of mutations in EGFR in circulating lung-cancer cells [J].N Engl J Med,2008,359(4):366-377.
[4]Schwarzenbach H,Chun FK,Lange I,et al.Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer [J].Int J Cancer,2007,120(7):1465-1471.
[5]Takagi R,Nakamoto D,Mizoe JE,et al.LOH analysis of free DNA in the plasma of patients with mucosal malignant melanoma in the head and neck [J].Int J Clin Oncol，2007,12(3):199-204.
[6] Muller I,Beeger C,Alix-Panabieres C,et al.Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients:potential and technical improvements [J].Clin Chem,2008, 54(4):688-696.
[7]Schwarzenbach H,Chun FK,Muller I,et al.Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer [J].BJU Int,2008,102(2):253-258.
[8]Tan SH, Ida H, Lau QC, et al. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3 [J].Oncol Rep,2007,18(5):1225-1230.
[9] Ellinger J,El Kassem N,Heukamp LC,et al.Hypermethylat- ion of cell-free serum DNA indicates worse outcome in patients with bladder cancer [J].J Urol,2008,179(1):346-352.
[10]Ellinger J,Haan K,Heukamp LC,et al.CpG island hypermet- hylation in cell-free serum DNA identifies patients with localized prostate cancer [J].Prostate,2008,68(1):42-49.
[11]Martinez-Galan J, Torres B, Del Moral R, et al. Quantitat- ive detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy [J].Cancer Biol Ther, 2008, 7(6):958-965.
[12]Sirera R, Gil M, Blasco A, et al. Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancer [J]. Lung cancer (Amsterdam, Netherlands), 2008, 61(1):104-108.
[13]Wang J,Kataoka H,Suzuki M,et al. Downregulation of EphA7 by hypermethylation in colorectal cancer [J].Oncogene,2005,24(36):5637-5647.
[14]Ikoma D,Ichikawa D,Ueda Y,et al.Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer [J].Anticancer Res,2007,27(1B):535-539.
[15]Nakayama G,Hibi K,Kodera Y,et al.P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma [J].Anticancer Res,2007,27(5A):3367-3370.
[16]Wang J,Li G,Ma H,et al.Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma [J].Hum Pathol,2007,38(11):1649-1656.
[17]Wang JD,Dong YC,Sheng Z,et al.Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis [J].Oncology,2007,73(3-4):238-245.
[18]Dong Y, Wang J, Sheng Z, et al. Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis [J]. Mod Pathol, 2009, 22(1):151-160.

相似文献/References: